💯 agree with the authors’ conclusion!
1. LMWH unavailable for non-surgical patients in Japan
2. SCDs incentivized in Japan despite limited evidence in medical patients
3. Padua score not validated in East Asian countries
Differences from Prior Guideline:
"Extension of watchful waiting (without antibiotic therapy) as an initial management strategy to all patients with uncomplicated acute bacterial rhinosinusitis (ABRS) regardless of severity"
https://t.co/ELj2sPvAiT